Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease

scientific article

Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/JNNP-2015-311321
P698PubMed publication ID26746185
P5875ResearchGate publication ID289687154

P50authorJohn Anthony HardyQ6237755
Henrik ZetterbergQ6252048
Martin R. TurnerQ39982364
Niklas MattssonQ57012884
P2093author name stringJonathan M Schott
P2860cites workPredicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomographyQ21146623
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's diseaseQ36632494
Age-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 miceQ36890888
Neuronal calcium mishandling and the pathogenesis of Alzheimer's diseaseQ36934762
Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's diseaseQ37010623
Handedness and language learning disability differentially distribute in progressive aphasia variantsQ37256206
Clinical syndromes associated with posterior atrophy: early age at onset AD spectrumQ37420383
Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathologyQ37699200
Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degenerationQ37899995
The amyloid state of proteins in human diseasesQ37994283
Logopenic aphasia in Alzheimer's disease: clinical variant or clinical feature?Q38030310
Alzheimer's disease: mimics and chameleons.Q38059197
Does variation in neurodegenerative disease susceptibility and phenotype reflect cerebral differences at the network level?Q38123554
Tools and talk: an evolutionary perspective on the functional deficits associated with amyotrophic lateral sclerosisQ38165909
The physical chemistry of the amyloid phenomenon: thermodynamics and kinetics of filamentous protein aggregationQ38240692
Amyloid-beta dynamics correlate with neurological status in the injured human brainQ42241419
Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroupsQ45304952
Age-dependent modification of proteins: N-terminal racemizationQ45841436
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's diseaseQ48408159
CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findingsQ48559548
Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease.Q49125003
The selfish brain: competition for energy resourcesQ56867013
Posterior cortical atrophyQ57384523
Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseasesQ58292492
Clearance systems in the brain-implications for Alzheimer diseaseQ26801541
Neurodegenerative diseases: expanding the prion conceptQ27011744
Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatmentsQ27024117
Closing the tau loop: the missing tau mutationQ27303641
The corticobasal syndrome-Alzheimer's disease conundrumQ28250881
Prion propagation and toxicity in vivo occur in two distinct mechanistic phasesQ28306079
Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memoryQ29614724
APP processing and synaptic functionQ29615873
The logopenic/phonological variant of primary progressive aphasiaQ30487374
Selective neuronal loss in ischemic stroke and cerebrovascular diseaseQ30689231
Cerebrospinal fluid biomarkers in clinical subtypes of early-onset Alzheimer's diseaseQ33756751
Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer's diseaseQ33784013
Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burdenQ33803956
Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia.Q33805339
Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.Q33926731
The diagnosis of young-onset dementia.Q34165340
Posterior cortical atrophyQ34177264
TDP-43 is a key player in the clinical features associated with Alzheimer's diseaseQ34232167
Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directionsQ34237637
The aging brain: morphomolecular senescence of cortical circuitsQ34349216
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's diseaseQ34635272
Synaptic retrogenesis and amyloid-beta in Alzheimer's diseaseQ34926455
Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distributionQ34999321
Neuronal activity regulates the regional vulnerability to amyloid-β depositionQ35009626
Global gray matter changes in posterior cortical atrophy: a serial imaging studyQ35176229
Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophyQ35241767
Lifespan brain activity, β-amyloid, and Alzheimer's diseaseQ35510426
Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometryQ35543363
Defining and describing the pre-dementia stages of familial Alzheimer's diseaseQ35557612
Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer diseaseQ35661053
Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's diseaseQ35735066
Prion-like spread of protein aggregates in neurodegenerationQ35946138
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological featuresQ36217479
Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodiesQ36315342
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectAlzheimer's diseaseQ11081
neurodegenerationQ1755122
P304page(s)1000-1004
P577publication date2016-01-08
P1433published inJournal of Neurology, Neurosurgery and PsychiatryQ1599804
P1476titleSelective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease
P478volume87

Reverse relations

cites work (P2860)
Q50161290A method for inferring regional origins of neurodegeneration
Q57134138Altered topology of the functional speech production network in non-fluent/agrammatic variant of PPA
Q93093190Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation
Q60530541Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis
Q39251035Applying fluid biomarkers to Alzheimer's disease
Q64948055C9orf72-mediated ALS and FTD: multiple pathways to disease.
Q64980907Calcium-Binding Proteins as Determinants of Central Nervous System Neuronal Vulnerability to Disease.
Q40518074Clinical heterogeneity in familial Alzheimer's disease
Q46837391Distinct spatiotemporal patterns of neuronal functional connectivity in primary progressive aphasia variants
Q52582190Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis.
Q46682283Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
Q54946040Molecular biomarkers of Alzheimer's disease: progress and prospects.
Q91786497Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
Q47161310Propofol Induces Apoptosis of Neurons but Not Astrocytes, Oligodendrocytes, or Neural Stem Cells in the Neonatal Mouse Hippocampus
Q33653691Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease
Q37127867Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model
Q47778608Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease
Q37690530Robust Identification of Alzheimer's Disease subtypes based on cortical atrophy patterns
Q91705233Selective vulnerability in neurodegenerative diseases
Q51760891Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.

Search more.